A Review of Hyperglycemia in COVID-19
Diabetes mellitus (DM) is one of the most common chronic metabolic disorders worldwide, which increases the risk of common and opportunistic infections. Following the coronavirus disease 2019 (COVID-19) pandemic, a higher incidence rate, more severe forms of the disease, and exacerbation of hypergly...
Gespeichert in:
| Veröffentlicht in: | Curēus (Palo Alto, CA) CA), 2023-04, Vol.15 (4), p.e37487-e37487 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e37487 |
|---|---|
| container_issue | 4 |
| container_start_page | e37487 |
| container_title | Curēus (Palo Alto, CA) |
| container_volume | 15 |
| creator | Zahedi, Maryam Kordrostami, Saba Kalantarhormozi, Mohammadreza Bagheri, Marziyeh |
| description | Diabetes mellitus (DM) is one of the most common chronic metabolic disorders worldwide, which increases the risk of common and opportunistic infections. Following the coronavirus disease 2019 (COVID-19) pandemic, a higher incidence rate, more severe forms of the disease, and exacerbation of hyperglycemia and its complications have been observed in patients with DM. Moreover, stress-induced hyperglycemia has been observed in many hospitalized nondiabetic patients after contracting COVID-19. Hyperglycemia worsens prognosis in both diabetic and nondiabetic patients. In this study, the mechanism of new-onset or exacerbation of hyperglycemia, the effect of the treatments used for COVID-19 on hyperglycemia, the importance and appropriate method of blood glucose (blood sugar (BS)) control during the disease, and the possible fate of new-onset hyperglycemia after recovery from COVID-19 to some extent is expressed. |
| doi_str_mv | 10.7759/cureus.37487 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10181889</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2814524668</sourcerecordid><originalsourceid>FETCH-LOGICAL-c343t-c6d1cf047e6108fb70b1ef78c78c853713935bea957889ac9b6ca51c8d6c28183</originalsourceid><addsrcrecordid>eNpdkc1LAzEQxYMottTePMuCCD24Ndlkk-xJSv1ooVAQ9Rqy6Wzdsh816Vb635vaWqoQSGB-eW9mHkKXBPeFiJM701hoXJ8KJsUJakeEy1ASyU6P3i3UdW6BMSZYRFjgc9SigkjBGWujm0HwAuscvoI6C0abJdh5sTFQ5jrIq2A4fR8_hCS5QGeZLhx093cHvT09vg5H4WT6PB4OJqGhjK5Cw2fEZJgJ4ATLLBU4JZAJafyRsTelCY1T0EkspEy0SVJudEyMnHET-VZpB93vdJdNWsLMQLWyulBLm5fablStc_W3UuUfal6vFcHE_5eJV-jtFWz92YBbqTJ3BopCV1A3TnkbFkeM863Z9T90UTe28vN5KiLRlok9dbujjK2ds5AduiFYbTNQuwzUTwYevzqe4AD_bpx-AyN7gG4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2821266835</pqid></control><display><type>article</type><title>A Review of Hyperglycemia in COVID-19</title><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Zahedi, Maryam ; Kordrostami, Saba ; Kalantarhormozi, Mohammadreza ; Bagheri, Marziyeh</creator><creatorcontrib>Zahedi, Maryam ; Kordrostami, Saba ; Kalantarhormozi, Mohammadreza ; Bagheri, Marziyeh</creatorcontrib><description>Diabetes mellitus (DM) is one of the most common chronic metabolic disorders worldwide, which increases the risk of common and opportunistic infections. Following the coronavirus disease 2019 (COVID-19) pandemic, a higher incidence rate, more severe forms of the disease, and exacerbation of hyperglycemia and its complications have been observed in patients with DM. Moreover, stress-induced hyperglycemia has been observed in many hospitalized nondiabetic patients after contracting COVID-19. Hyperglycemia worsens prognosis in both diabetic and nondiabetic patients. In this study, the mechanism of new-onset or exacerbation of hyperglycemia, the effect of the treatments used for COVID-19 on hyperglycemia, the importance and appropriate method of blood glucose (blood sugar (BS)) control during the disease, and the possible fate of new-onset hyperglycemia after recovery from COVID-19 to some extent is expressed.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.37487</identifier><identifier>PMID: 37187644</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Coronaviruses ; COVID-19 ; Diabetes ; Endocrinology/Diabetes/Metabolism ; Hyperglycemia ; Infectious Disease ; Insulin resistance ; Medical prognosis ; Mortality</subject><ispartof>Curēus (Palo Alto, CA), 2023-04, Vol.15 (4), p.e37487-e37487</ispartof><rights>Copyright © 2023, Zahedi et al.</rights><rights>Copyright © 2023, Zahedi et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2023, Zahedi et al. 2023 Zahedi et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c343t-c6d1cf047e6108fb70b1ef78c78c853713935bea957889ac9b6ca51c8d6c28183</citedby><cites>FETCH-LOGICAL-c343t-c6d1cf047e6108fb70b1ef78c78c853713935bea957889ac9b6ca51c8d6c28183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181889/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181889/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37187644$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zahedi, Maryam</creatorcontrib><creatorcontrib>Kordrostami, Saba</creatorcontrib><creatorcontrib>Kalantarhormozi, Mohammadreza</creatorcontrib><creatorcontrib>Bagheri, Marziyeh</creatorcontrib><title>A Review of Hyperglycemia in COVID-19</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Diabetes mellitus (DM) is one of the most common chronic metabolic disorders worldwide, which increases the risk of common and opportunistic infections. Following the coronavirus disease 2019 (COVID-19) pandemic, a higher incidence rate, more severe forms of the disease, and exacerbation of hyperglycemia and its complications have been observed in patients with DM. Moreover, stress-induced hyperglycemia has been observed in many hospitalized nondiabetic patients after contracting COVID-19. Hyperglycemia worsens prognosis in both diabetic and nondiabetic patients. In this study, the mechanism of new-onset or exacerbation of hyperglycemia, the effect of the treatments used for COVID-19 on hyperglycemia, the importance and appropriate method of blood glucose (blood sugar (BS)) control during the disease, and the possible fate of new-onset hyperglycemia after recovery from COVID-19 to some extent is expressed.</description><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Diabetes</subject><subject>Endocrinology/Diabetes/Metabolism</subject><subject>Hyperglycemia</subject><subject>Infectious Disease</subject><subject>Insulin resistance</subject><subject>Medical prognosis</subject><subject>Mortality</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkc1LAzEQxYMottTePMuCCD24Ndlkk-xJSv1ooVAQ9Rqy6Wzdsh816Vb635vaWqoQSGB-eW9mHkKXBPeFiJM701hoXJ8KJsUJakeEy1ASyU6P3i3UdW6BMSZYRFjgc9SigkjBGWujm0HwAuscvoI6C0abJdh5sTFQ5jrIq2A4fR8_hCS5QGeZLhx093cHvT09vg5H4WT6PB4OJqGhjK5Cw2fEZJgJ4ATLLBU4JZAJafyRsTelCY1T0EkspEy0SVJudEyMnHET-VZpB93vdJdNWsLMQLWyulBLm5fablStc_W3UuUfal6vFcHE_5eJV-jtFWz92YBbqTJ3BopCV1A3TnkbFkeM863Z9T90UTe28vN5KiLRlok9dbujjK2ds5AduiFYbTNQuwzUTwYevzqe4AD_bpx-AyN7gG4</recordid><startdate>20230412</startdate><enddate>20230412</enddate><creator>Zahedi, Maryam</creator><creator>Kordrostami, Saba</creator><creator>Kalantarhormozi, Mohammadreza</creator><creator>Bagheri, Marziyeh</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230412</creationdate><title>A Review of Hyperglycemia in COVID-19</title><author>Zahedi, Maryam ; Kordrostami, Saba ; Kalantarhormozi, Mohammadreza ; Bagheri, Marziyeh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c343t-c6d1cf047e6108fb70b1ef78c78c853713935bea957889ac9b6ca51c8d6c28183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Diabetes</topic><topic>Endocrinology/Diabetes/Metabolism</topic><topic>Hyperglycemia</topic><topic>Infectious Disease</topic><topic>Insulin resistance</topic><topic>Medical prognosis</topic><topic>Mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zahedi, Maryam</creatorcontrib><creatorcontrib>Kordrostami, Saba</creatorcontrib><creatorcontrib>Kalantarhormozi, Mohammadreza</creatorcontrib><creatorcontrib>Bagheri, Marziyeh</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zahedi, Maryam</au><au>Kordrostami, Saba</au><au>Kalantarhormozi, Mohammadreza</au><au>Bagheri, Marziyeh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Review of Hyperglycemia in COVID-19</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2023-04-12</date><risdate>2023</risdate><volume>15</volume><issue>4</issue><spage>e37487</spage><epage>e37487</epage><pages>e37487-e37487</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Diabetes mellitus (DM) is one of the most common chronic metabolic disorders worldwide, which increases the risk of common and opportunistic infections. Following the coronavirus disease 2019 (COVID-19) pandemic, a higher incidence rate, more severe forms of the disease, and exacerbation of hyperglycemia and its complications have been observed in patients with DM. Moreover, stress-induced hyperglycemia has been observed in many hospitalized nondiabetic patients after contracting COVID-19. Hyperglycemia worsens prognosis in both diabetic and nondiabetic patients. In this study, the mechanism of new-onset or exacerbation of hyperglycemia, the effect of the treatments used for COVID-19 on hyperglycemia, the importance and appropriate method of blood glucose (blood sugar (BS)) control during the disease, and the possible fate of new-onset hyperglycemia after recovery from COVID-19 to some extent is expressed.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>37187644</pmid><doi>10.7759/cureus.37487</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2168-8184 |
| ispartof | Curēus (Palo Alto, CA), 2023-04, Vol.15 (4), p.e37487-e37487 |
| issn | 2168-8184 2168-8184 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10181889 |
| source | PubMed Central; PubMed Central Open Access |
| subjects | Coronaviruses COVID-19 Diabetes Endocrinology/Diabetes/Metabolism Hyperglycemia Infectious Disease Insulin resistance Medical prognosis Mortality |
| title | A Review of Hyperglycemia in COVID-19 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T01%3A22%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Review%20of%20Hyperglycemia%20in%20COVID-19&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Zahedi,%20Maryam&rft.date=2023-04-12&rft.volume=15&rft.issue=4&rft.spage=e37487&rft.epage=e37487&rft.pages=e37487-e37487&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.37487&rft_dat=%3Cproquest_pubme%3E2814524668%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2821266835&rft_id=info:pmid/37187644&rfr_iscdi=true |